Cargando…

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES

Detalles Bibliográficos
Autores principales:	Assanto, Giovanni Manfredi, Salvatori, Martina, Pontecorvo, Sara, Maiorana, Gianluca, Cenfra, Natalia, D’elia, Gianna Maria, Bianchi, Maria Paola, Annechini, Giorgia, Santoro, Cristina Santoro, Martelli, Maurizio, Tafuri, Agostino, Pulsoni, Alessandro, Del Giudice, Ilaria, Chistolini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428474/ http://dx.doi.org/10.1097/01.HS9.0000967788.70014.0a

Ejemplares similares

High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021)

P1175: THROMBOTIC RISK IN DLBCL: A REAL-LIFE COMPARISON OF THE THROLY AND MODEL IX SCORES
por: Civettini, Ivan, et al.
Publicado: (2023)

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?
por: Pulsoni, A., et al.
Publicado: (2023)

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy
por: Perrone, Salvatore, et al.
Publicado: (2016)

Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital
por: Bermejo, Lara Almudena Fernández, et al.
Publicado: (2022)

The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
por: Assanto, Giovanni M., et al.
Publicado: (2021)

Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment
por: Di Rocco, Alice, et al.
Publicado: (2022)

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)

Har Gobind Khorana (1922–2011): Pioneering Spirit
por: Sakmar, Thomas P.
Publicado: (2012)

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
por: Rupa‐Matysek, Joanna, et al.
Publicado: (2018)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
por: Mancuso, Salvatrice, et al.
Publicado: (2020)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
por: Accurso, Vincenzo, et al.
Publicado: (2020)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Learning from Gobind Khorana: “The difficult we do today, the impossible tomorrow”
por: Subramaniam, Sriram
Publicado: (2022)

Expression systems for bovine rhodopsin: a review of the progress made in the Khorana laboratory
por: Reeves, Philip J.
Publicado: (2023)

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
por: Zhang, Yu-Feng, et al.
Publicado: (2023)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

S219. RISK FACTORS FOR LOW BONE MINERAL DENSITY IN PATIENTS TAKING ANTIPSYCHOTICS
por: Jhon, Min, et al.
Publicado: (2018)

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”
Publicado: (2020)

Immune thrombocytopenia management during COVID‐19 pandemic: An Italian monocentric experience
por: Lapietra, Gianfranco, et al.
Publicado: (2022)

Polonaise op. 219 no. 3 /
por: Popp, Wilhelm

M219. OVERESTIMATING FUNCTION – A RISK FACTOR FOR SUBOPTIMAL COMMUNITY AID IN SCHIZOPHRENIA
por: Pontén, Anna, et al.
Publicado: (2020)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2023)

My remembrances of H.G. Khorana: exploring the mechanism of bacteriorhodopsin with site-directed mutagenesis and FTIR difference spectroscopy
por: Rothschild, Kenneth J.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r7tift21sggdv3rh7mfi86jcfa